Riskpilot← Back to searchSign inGet full accessC SPESIALIST AS
ASActiveOrg 818576552Sørkedalsveien 10C, 0369 OsloGeneral medical practice activities · NACE 8621Est. 20171 employees
Revenue 2024
NOK 4,5M
-10% vs 2023
EBITDA margin
-6.3%
-857% vs 2023
Equity ratio
64.6%
Financial strength
Net profit 2024
NOK -365K
-167% vs 2023
| Revenue | NOK 4,5M | -10% |
| EBITDA | NOK -288K | -857% |
| Net profit | NOK -365K | -167% |
| Total assets | NOK 4,6M | +21% |
| Equity | NOK 3M | -11% |
| Employees | 1 | — |
Legal name
C SPESIALIST AS
Org number
818576552
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
16. februar 2017
Share capital
NOK 4 430 193
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Medisinsk behandling, medisinsk konsulentvirksomhet og salg av medisinske artikler samt dertil forenlig virksomhet.
Address
Sørkedalsveien 10C, 0369 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 560 | 4 223 | 5 832 | 5 048 | 4 541 |
| Staff expenses | −2 007 | −656 | −144 | −95 | −922 |
| EBITDA | −886 | −72 | −56 | −30 | −288 |
| Depreciation & amort. | −101 | −84 | −111 | −106 | −76 |
| EBIT | −987 | −156 | −167 | −137 | −365 |
| Net financials | −5 | 2 | 2 | −0 | 0 |
| Profit before tax | −992 | −154 | −166 | −137 | −365 |
| Tax | −0 | −748 | −0 | −0 | −0 |
| Net profit | −992 | 594 | −166 | −137 | −365 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 752 | 4 186 | 4 308 | 3 809 | 4 597 |
| Equity | −4 008 | 3 635 | 3 470 | 3 333 | 2 968 |
| Long-term debt | 3 643 | 0 | 0 | 0 | 800 |
| Short-term debt | 1 117 | 551 | 839 | 476 | 829 |
| Total debt | 4 760 | 551 | 839 | 476 | 1 629 |
EBITDA margin
-6.3%
This company
15.8%
Market median
-140% vs market
20202024
Equity ratio
64.6%
This company
38.2%
Market median
+69% vs market
20202024
Return on equity
-12.3%
This company
18.4%
Market median
-167% vs market
20202024
Net profit margin
-8.0%
This company
8.1%
Market median
-199% vs market
20202024
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20202024
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (6) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Chairman | 2022 – 2024 | |
| Chairman | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 80% | 80% | 2023 | |
| Company | 20% | 20% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gullestad Medisinske Holding AsColosseumklinikken Medisinske Senter As
C SPESIALIST AS (this company)Board members of C SPESIALIST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Vidar Husnes | Board of Directors | 0 companies |
| Frank Roger Ystenes | Board of Directors | 0 companies |
| Owe Nythun | Board of Directors | 0 companies |
| Lars Kristian Glæsel Gullestad | Chairman | 0 companies |
| Helge Kolbjørn Knudsen | Chairman | 0 companies |
| Dagfinn Sverre Aarskog | Board of Directors | 0 companies |
| Erik Wahlstrøm | Board of Directors | 0 companies |
| Geir Ove Hauge | Board of Directors | 0 companies |
| Lars Kristian Gullestad | Chairman | 0 companies |